Veracity Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
BTCPP
AIM
PAS
GI
PNC
CCM
FFA
CNBT
VFA
PC
Veracity Capital's AZN Position: Q3 2026 in Review
Veracity Capital sold out of AstraZeneca (AZN) in Q3 2026, closing a stake of 1,623 shares — an estimated $308K sold.
Veracity Capital first reported a position in AZN in Q4 2019 and held it in 20 quarters. The position peaked at $476K in Q4 2019. 57 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Veracity Capital reported no remaining AstraZeneca position as of Q3 2026 after selling out during the quarter.
- Veracity Capital sold 1,623 AstraZeneca shares in Q3 2026, an estimated $308K.
- Veracity Capital first reported a position in AstraZeneca in Q4 2019 and held it in 20 quarters.
- Veracity Capital's AstraZeneca position peaked at $476K in Q4 2019.
- 57 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Veracity Capital's 13F filing for Q3 2026, filed 8 Oct 2026.